RUSSELL FRANK CO/ - OREXIGEN THERAPEUTICS INC ownership

OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 124 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.0%.

Quarter-by-quarter ownership
RUSSELL FRANK CO/ ownership history of OREXIGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2015$97,000
-50.0%
52,584
-42.8%
0.00%
Q3 2015$194,000
-64.5%
91,942
-16.7%
0.00%
-100.0%
Q2 2015$546,000
-59.8%
110,396
-36.4%
0.00%
-50.0%
Q1 2015$1,359,000
+754.7%
173,582
+560.2%
0.00%
Q4 2014$159,000
+42.0%
26,2920.0%0.00%
Q3 2014$112,000
-14.5%
26,2920.0%0.00%
Q2 2014$131,000
-9.7%
26,2920.0%0.00%
Q1 2014$145,000
-18.1%
26,2920.0%0.00%
Q4 2013$177,000
-82.7%
26,292
-84.3%
0.00%
-100.0%
Q3 2013$1,026,000
-3.0%
167,117
-7.6%
0.00%0.0%
Q2 2013$1,058,000180,9060.00%
Other shareholders
OREXIGEN THERAPEUTICS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,250,000$7,725,0006.48%
Ghost Tree Capital, LLC 250,000$1,545,0001.09%
Rock Springs Capital Management LP 905,000$5,593,0001.00%
Palo Alto Investors LP 1,931,324$11,936,0000.89%
PFM Health Sciences, LP 4,604,958$28,459,0000.57%
NEA Management Company, LLC 1,935,300$11,960,0000.56%
Rhenman & Partners Asset Management AB 300,199$1,855,0000.55%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 1,752,792$10,832,0000.50%
CQS Cayman LP 660,040$4,079,0000.25%
FARALLON CAPITAL MANAGEMENT LLC 2,684,300$16,589,0000.24%
View complete list of OREXIGEN THERAPEUTICS INC shareholders